{"id":"W2531276114","doi":"10.1200/jco.2013.31.15_suppl.2538","title":"A phase I trial and pharmacokinetic study of trebananib (AMG386) in children with recurrent or refractory solid tumors: A Children’s Oncology Group Phase 1 Consortium report.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Neutropenia; Sarcoma; Pharmacokinetics; Internal medicine; Rhabdomyosarcoma; Pazopanib; Toxicity; Gastroenterology; Oncology; Surgery; Urology; Sunitinib; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001644149,0.001366992,0.00159098,0.0003299551,0.0003762213,0.0005586324,0.0008807515,0.0009598169,0.00263449],"category_scores_gemma":[0.001003529,0.0005020804,0.00084862,0.0005514459,0.0008151516,0.0005901271,0.0002856358,0.00302471,0.0006869147],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001335829,"about_ca_system_score_gemma":0.002219074,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00231203,"about_ca_topic_score_gemma":0.00446329,"domain_scores_codex":[0.9995177,0.0002416825,0.00002753926,0.00007034013,0.00006146349,0.00008124671],"domain_scores_gemma":[0.9989556,0.0001825684,0.0002419501,0.0000793188,0.00005490177,0.00048561],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5281629,0.09349506,0.0444025,0.001281709,0.00201798,0.002723295,0.001325442,0.008494087,0.1362467,0.000774992,0.01516063,0.1659147],"study_design_scores_gemma":[0.4072628,0.5248212,0.04311518,0.00006865021,0.0004379958,0.002908032,0.0001171227,0.002570468,0.01084767,0.0002575607,0.007539495,0.00005392863],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939389,0.001095634,0.0006369162,0.0004250616,0.00004226855,0.001526691,0.001323731,0.00008527869,0.0009254607],"genre_scores_gemma":[0.9840444,0.00221841,0.004153154,0.0006676444,0.0001296471,0.002724301,0.004133245,0.00006656922,0.001862628],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00263449,"threshold_uncertainty_score":0.009692192,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07080242788697226,"score_gpt":0.4472772095604552,"score_spread":0.376474781673483,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}